Posted by Amy Clausen on Mon, Oct 05, 2009 @ 10:51 AM
MD Biosciences (MDB), a contract research organization offering
pre-clinical services and products in support of drug discovery for
inflammatory and neurological diseases, relocated its U.S. office from
1000 Westgate Dr, St Paul, MN to 2575 University Ave W, St Paul, MN on
October 3, 2009. The new location equips MD Biosciences with more lab
space, allowing for increased capacity for in vitro services and
product development and manufacturing to increase product offering.
Eddie
Moradian, President of MD Biosciences states, "At MD Biosciences, we
have always promised our clients that we will meet their needs now and
in the future; our expansion ensures that commitment. We doubled our
lab space so that we are able to provide 150 percent more services and
increase product development by 130 percent in the coming year in
comparison with the last.
Our relocation is just one step of
many in the endeavor to continue to offer the highest quality services
and products in assisting our customers in meeting their objectives.
Future projections include adding more highly specialized scientists to
our team and increasing our focus on our available products and
proprietary reagents."
About MD BiosciencesMD
Biosciences provides products and pre-clinical services, which include
efficacy testing, mode of action platforms, in vitro analysis,
histology and imaging for the Pharmaceutical, Medical Device and Animal
Health & Nutrition Industries. We offer several novel models in the
area of rheumatoid arthritis (RA), Multiple sclerosis, asthma, IBD,
pain, and Parkinson's disease. The in-depth expertise in these disease
models has been applied to designing protocols to assess the efficacy
and required dosage of novel compounds. Contracted studies are designed
and reviewed by MDB’s panel of internationally recognized experts and
performed at one of MDB’s specialized laboratories located in St. Paul,
MN (USA), Glasgow (Scotland) or in Israel . We provide a ready team of
experts to tackle problems and provide solutions. MDB also supplies for
purchase by all laboratories many of the products and proprietary
reagents used in our research, regardless of whether MDB is contracted
as a research organization. This allows our clients to optimize their
own research process by selecting steps to be performed by MDB and
research to be performed in-house.
###
The
information in this press release should be considered accurate only as
of the date of the release. MD Biosciences has no intention of updating
and specifically disclaims any duty to update the information in these
press releases.